Top Story

Despite promise, ‘maximum potential’ of precision medicine yet to be reached

HemOnc Today, May 25, 2015

Precision medicine has garnered tremendous public attention since President Barack Obama established it as a national priority during his State of the Union address.

The Precision Medicine Initiative — created with an initial $215 million investment — is intended to help researchers determine which treatments best target specific characteristics of each individual patient’s disease. Leaders expect to gain insights from tissue samples, as well as biological, environmental, lifestyle and behavioral information provided by at least 1 million volunteers.

David A. Williams, MD Association News

ASH announces training program participants

May 24, 2015
ASH and the European Hematology Association released the names of 20 early-career hematologists who are participating in the 2015 Translational Research in Hematology…
Martin McMahon, PhD Institution Notes

Cancer institute appoints senior director

May 23, 2015
Martin McMahon, PhD, has been appointed professor in the department of dermatology and senior director of pre-clinical translation at Huntsman Cancer Institute at the…
In the Journals

Statins may lower mortality risk in patients with lung cancer

May 22, 2015
Statin use in the year before and after diagnosis was linked to decreased mortality risk in patients with lung cancer, according to results of a population-based cohort…
Meeting News Coverage

Spirituality, religiosity increased quality of life among patients with cancer

May 22, 2015
TORONTO — Among patients with cancer, having a high sense of spirituality and/or religiosity increased mental health quality of life, according to data presented…
More News Headlines »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Meeting News Coverage Video
VIDEO: Updates in prostate cancer treatment options

VIDEO: Updates in prostate cancer treatment options

May 5, 2015
Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, discusses various forms of prostate cancer…
More »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »